Sanofi Consumer Healthcare IndiaNSE:SANOFICONR -1.39%21 Pretax Margin % is 39.57% as of Mar. 2026, which is 8% above its 10-year median of 36.48. GuruFocus rates NSE:SANOFICONR with a GF Score™ of 21/100. The stock has 2 warning signs investors should review. Among 956 Drug Manufacturers companies, Sanofi Consumer Healthcare India ranks better than 95.19% on this metric.
The historical rank and industry rank for Sanofi Consumer Healthcare India's Pretax Margin % or its related term are showing as below:
NSE:SANOFICONR'
s Pretax Margin % Range Over the Past 10 Years
Min: 34.46 Med: 36.48 Max: 40.29
Current: 36.81
NSE:SANOFICONR's Pretax Margin % is ranked better than 95.19% of 956
companies
in the Drug Manufacturers industry
Industry Median: 7.285
vs NSE:SANOFICONR: 36.81
Sanofi Consumer Healthcare India (NSE:SANOFICONR) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Sanofi Consumer Healthcare India Pretax Margin % Related Terms
Sanofi Consumer Healthcare India Pretax Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sanofi Consumer Healthcare India Pretax Margin % Chart
NSE:SANOFICONR vs LLY, JNJ, ABBV: Pretax Margin % Comparison
For the Drug Manufacturers - General subindustry, Sanofi Consumer Healthcare India's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sanofi Consumer Healthcare India Pretax Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sanofi Consumer Healthcare India's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Sanofi Consumer Healthcare India's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sanofi Consumer Healthcare India (NSE:SANOFICONR) has a Pretax Margin % of 39.57% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Sanofi Consumer Healthcare India and its competitors. This is near median its historical median of 36.48. Over the past decade, Sanofi Consumer Healthcare India's Pretax Margin % has ranged from 34.46 to 40.29. According to the industry distribution chart, Sanofi Consumer Healthcare India ranks #46 out of 956 companies in the Drug Manufacturers industry, placing it in the top 4.8%.
Is Sanofi Consumer Healthcare India's Pretax Margin % too high?
Sanofi Consumer Healthcare India's current Pretax Margin % of 39.57% is near median its 10-year median of 36.48. Over the past 10 years, this metric has ranged from a low of 34.46 to a high of 40.29. The Drug Manufacturers industry median Pretax Margin % is 7.29. Sanofi Consumer Healthcare India's value of 39.57% is 443.2% above this industry median. Based on the distribution chart, Sanofi Consumer Healthcare India ranks #46 out of 956 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Sanofi Consumer Healthcare India has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Sanofi Consumer Healthcare India's Pretax Margin % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Sanofi Consumer Healthcare India ranks #46 out of 956 companies for Pretax Margin %. This places Sanofi Consumer Healthcare India in the top 5% of its industry — outperforming the majority of peers. The industry median Pretax Margin % is 7.29. Sanofi Consumer Healthcare India's value of 39.57% is 443.2% above this benchmark. Historically, Sanofi Consumer Healthcare India's own Pretax Margin % has ranged from 34.46 to 40.29 over the past decade. While the company's 10-year median is 36.48 vs. the industry median of 7.29, Sanofi Consumer Healthcare India has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Drug Manufacturers company?
The median Pretax Margin % among Drug Manufacturers companies is 7.29, based on 956 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sanofi Consumer Healthcare India's current Pretax Margin % of 39.57% is 443.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Sanofi Consumer Healthcare India and its competitors. For the Drug Manufacturers industry, the median Pretax Margin % is 7.29 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sanofi Consumer Healthcare India's current Pretax Margin % is 39.57%, which is near median its own 10-year median of 36.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sanofi Consumer Healthcare India stock overvalued right now?
Sanofi Consumer Healthcare India (NSE:SANOFICONR) has a current Pretax Margin % of 39.57%. The current Pretax Margin % is 39.57%, which is near median its 10-year median of 36.48 and 443.2% above the Drug Manufacturers industry median of 7.29. Sanofi Consumer Healthcare India's overall GF Score™ is 21/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Sanofi Consumer Healthcare India (NSE:SANOFICONR), the current Pretax Margin % is 39.57% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Sanofi Consumer Healthcare India Business Description
Sanofi Consumer Healthcare India Ltd is mainly engaged in the business of manufacturing and trading of drugs and pharmaceutical products. The Company also has various independent contract/third-party manufacturers based across the country and provides business support services to its group entity in India. Its products include Allergy Relief (Allegra), Pain Care (Combiflam), and Physical Wellness (DePURA). The Company sells its products in India through independent distributors and outside India. Its operations are limited to one segment, namely Pharmaceutical Business. The Company operates in India, which generates the maximum revenue, and Outside India.
21GF Score
Get the complete analysis for NSE:SANOFICONR
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:SANOFICONR has been successfully added to your 
